Organized by the MySphera Chair at Universitat Politècnica de València, a series of 5 webinars will be held on “The new challenges of health after the pandemic”. In them, each with a different theme but always with health and technologies as the guiding axis, some relevant personalities from the health and ICT sectors will participate and answer a series of questions, also guiding the student and all professionals who want to assist on new needs and trends in the sector, which will facilitate the student’s job placement and a closer proximity of the teacher to our society.
All these webinars will be recorded for later reproduction and, in addition, the different speakers will be interviewed so that a book on the changes that society and the health system has experienced and will experience, will be presented at the end of the year.
The webinars will take place every Wednesday from 4pm to 5pm starting this week. The first of them, “Contact Tracing – Initiatives for detection, containment and traceability of infections”, will take place on Wednesday June 17 and will feature experts Víctor Álvarez (CEO / SITUM), Javier Bosch (CEO / NB23-Social Distance) , Julio Jesús Sánchez (Manager of e-Health projects and digital businesses / Telefónica) and Eduardo Montón (CTO / MYSPHERA).
Full information on the webinars can be found here.
Registration to the first of them can be done from here.
An ecological building system based on natural biological materials to improve energy efficiency in public buildings
A series of 5 webinars organized by the MySphera Chair at UPV
June 29 – July 2, 2020 (Online)
The Early-Stage Researcher of ITACA will present his paper on September 14.
BUBBLES will lay the foundations for a new U-Space Separation Management service.
Vicente Traver advocates the use of ICTs in Health
European Technology and Innovation Platform on Renewable Heating and Cooling
Las Naves and the UPV extend the fight against loneliness of the elderly
ITACA wishes you a Merry Christmas and a 2020 full of projects
Methodology that improves the follow-up of patients with glioblastoma